Subscribe To
lonza: the day has come, and we lower our expectation
Here at the Lab, post Capital Market Day, we are in a show-me-story scenario. Moderna contract termination is a positive short-term catalyst; however,...
October 18, 2023, 4:43 am
lonza group: downside scenario already priced in
lonza's CEO departure raises questions about business continuity, but we believe the stock price alread...
October 5, 2023, 4:55 am
Moderna to cut mrna drug substance production at lonza facility
Moderna said on Tuesday it will cut production of mRNA drug substance for its COVID-19 vaccine at lonza...
September 19, 2023, 10:56 am
Lonza cites biotech funding slowdown as it lowers sales outlook for the year
Contract manufacturer lonza tempered its sales outlook for the rest of the year due in part to lower-th...
July 21, 2023, 3:14 pm
lonza delivers 5.6% cer sales growth, with underlying growth at around 10% cer and 30% core ebitda margin
CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Ad hoc announcem...
July 21, 2023, 5:29 am
lonza: our thoughts pre capital market day, buy confirmed
Despite a challenging economic environment, lonza announced an increase in CAPEX, positioning itself to...
June 30, 2023, 3:41 am
lonza group ag (lzagy) q1 2023 earnings call transcript
lonza Group AG (OTCPK:LZAGY) Q1 2023 Earnings Conference Call May 9, 2023 9:00 AM ET Company Participan...
May 10, 2023, 3:30 pm
Global tertiary amines market size forecasted to surpass $7.5 billion growth by 2030, exhibit a cagr of 6.12%
Global Tertiary Amines Market size & share revenue was valued at around USD 4.65 billion in 2022 and is estimated to grow about USD 7.5 billion by 203...
May 1, 2023, 7:11 am
lonza launches share buyback program of up to chf 2 billion
lonza Launches Share Buyback Program of up to CHF 2 Billion 31.03.2023 / 07:00 CET/CEST Basel, Switzerl...
March 31, 2023, 5:29 am
lonza group ag (lzagy) q4 2022 earnings call transcript
lonza Group AG (OTCPK:LZAGY) Q4 2022 Earnings Conference Call January 25, 2023 8:00 AM ET Company Parti...
January 25, 2023, 12:36 pm
lonza fy22 profit up, lifts dividend; sees higher fy23 sales, weak margin; plans chf 2 bln buyback
lonza Group AG (LZAGF.PK), a supplier to the pharmaceutical, healthcare and life-science industries, re...
January 25, 2023, 7:14 am
lonza delivers strong 2022 performance with 15.1% cer sales growth and 32.1% core ebitda margin
CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Ad hoc announcem...
January 25, 2023, 6:29 am
Context therapeutics announces manufacturing agreement with lonza for bispecific antibody targeting claudin 6 positive cancers
Context Therapeutics (NASDAQ:CNTX) Inc said it will be collaborating with lonza, a global development a...
January 9, 2023, 9:03 am
lonza group ag (lzagy) ceo pierre-alain ruffieux on q2 2022 results - earnings call transcript
lonza Group AG (OTCPK:LZAGY) Q2 2022 Earnings Conference Call July 22, 2022 8:00 AM ET Company Particip...
July 22, 2022, 7:59 pm
lonza: one stop shop for global drug manufacturing, at a price
lonza is the largest pure-play CDMO in the world. While pharmaceuticals and biotechs need to spend on r...
June 16, 2022, 1:54 pm